BSPM
Biostar Pharmaceuticals, Inc.
BSPM
BSPM
Delisted
BSPM was delisted on the 18th of September, 2018.
5 hedge funds and large institutions have $20K invested in Biostar Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$18K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Acadian Asset Management
Boston,
Massachusetts
| $18K | 11,464 | +3,548 | +45% |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | 1,188 | +188 | +19% |
|
3
Morgan Stanley
New York
| $0 | 24 | -31,150 | -100% |
|
4
JPMorgan Chase & Co
New York
| – | – | -29,282 | Closed |
|
|
AIM
5
Acrospire Investment Management
Chicago,
Illinois
| – | – | -11,740 | Closed |
|
6
Barclays
London,
United Kingdom
| – | – | -1,000 | Closed |
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 401 | – | – |
|
|
AG
8
Advisor Group
Phoenix,
Arizona
| $0 | 39 | +39 | New |
|